CASR and Hypocalcemia: As NPSP795 rectified the altered signaling responses associated with the Nuf mouse CaSR mutation (Leu723Gln) in vitro, we pursued studies to determine the effects of this calcilytic in Nuf mice, which have hypocalcemia and reduced plasma PTH concentrations (Table 1).